相关实验视频

Updated: Jul 6, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌移植的免疫疗法:辅助治疗的下一个前沿

Parissa Tabrizian¹, Marcus Zeitlhoefler, Ahmed Talaat Hassan

¹Liver Transplant and Hepatobiliary Surgery, Recanati-Miller Transplantation Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Current opinion in organ transplantation

|January 2, 2024

概括

免疫检查点抑制剂 (ICI) 正在彻底改变肝细胞癌 (HCC) 肝移植的方法. 本综述探讨了它们在改善结果和管理肝移植后复发后的用途.

科学领域:

肝胆道手术肝胆道手术
免疫治疗是一种免疫疗法.
肝细胞癌研究肝细胞癌研究

背景情况:

对肝细胞癌 (HCC) 的肝移植越来越成功.
免疫瘤学的进步突出了免疫检查点抑制剂 (ICI) 对于HCC治疗.
在管理先进的HCC和移植后复发方面,ICI至关重要.

研究的目的:

为提供肝脏移植中ICI的最新概述.
探索新辅助和辅助ICI策略. 为了探索新辅助和辅助ICI战略.
为解决肝移植中ICI的安全性,患者选择和响应预测因素.

主要方法:

对肝脏移植中ICI的当前文献的综述.
对新辅助剂和辅助剂ICI应用的分析.
安全性,疗效和患者选择标准的评估.

主要成果:

在肝移植的患者下降阶段,ICI显得有前途.
由于适当的免疫抑制和洗期,人们对移植物排斥的担忧得到了缓解.
ICI提供了一种应对移植后HCC复发的策略.

结论:

ICI是先进的HCC治疗和肝移植协议的组成部分.
在移植后复发的关键是平衡免疫疗法的疗效与移植功能的保护.
需要进行进一步的临床试验,以验证风险/益处比率,并确定肝移植中ICI的清晰管理途径.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...